Back

Leukocyte extracellular vesicles as the first biomarkers to predict outcomes in patients undergoing percutaneous aortic valve replacement

29 August 2022 (09:15 - 10:00)
Organised by:
Congress Presentation Part of: Predictors of outcomes in transcatheter aortic valve replacement Aortic Valve Stenosis ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Assistant Professor Aleksandra Gasecka

Medical University of Warsaw, Warsaw (Poland)

6 More presentations in this session

Presentation thumbnail
Albuminuria predicts worsening renal function at 1 month after transcatheter aortic valve implantation
Doctor A. Tobe (Galway, IE)
Abstract Slides
Presentation thumbnail
Association of left ventricular myocardial work with all-cause mortality after transcatheter aortic valve implantation
Doctor S. Nussbaum (Zurich, CH)
Abstract Slides
Presentation thumbnail
Clinical determinants of non-invasive global myocardial work index before and after transcatheter aortic valve implantation: a prospective study
Doctor B. Lakatos (Budapest, HU)
Abstract Slides
Presentation thumbnail
Global longitudinal strain and NT-proBNP as predictors for LV function recovery after TAVR
Miss A. Moya (Aalst, BE)
Abstract Slides
Presentation thumbnail
Long-term survival and outcomes according to age for patients underwent to transcatheter aortic valve replacement
Doctor M. Munoz-Garcia (Ciudad Real, ES)
Abstract Slides

Access the full session

Session thumbnail
Predictors of outcomes in transcatheter aortic valve replacement

The Event

Event poster

ESC Congress 2022

29 August 2022 09:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources